{
  "abstract": "A crucial study that enabled the vasculitis drug avacopan, branded as Tavneos, to gain regulatory approval has been retracted by the New England Journal of Medicine (NEJM).1",
  "authors": [
    {
      "affiliations": [
        "Belfast"
      ],
      "name": "Chris Baraniuk"
    }
  ],
  "title": "Trial paper is retracted as FDA keeps scrutiny on controversial vasculitis drug",
  "uid": "199b1425-89af-5147-99c9-fab63d1adee0"
}